Effects of Whole Body Vibration on Postmenopausal Risk-factors in Elderly Women

Sponsor
University of Erlangen-Nürnberg Medical School (Other)
Overall Status
Terminated
CT.gov ID
NCT00667667
Collaborator
Elsbeth-Bonhoff-Stiftung, Berlin (Other)
108
1
3
19
5.7

Study Details

Study Description

Brief Summary

There is general agreement that physical exercise can positively influence osteoporotic fracture risk along two pathways: first by reducing the risk of falls via an improvement of fall related neuromuscular abilities; second by increasing bone strength.

Whole body vibration (WBV) training has recently been proposed as a new approach for prevention and treatment of osteoporosis. Animal studies have shown evidence that WBV may be an effective method to improve bone mass, architecture and strength. However, the results of human WBV training studies are rather heterogeneous.

In the Erlangen Longitudinal Vibration Study II (ELVIS II), a randomized, controlled 12 month lasting study the investigators determine the effect of a thrice weekly WBV training on two different devices on the osteoporotic risk factors: bone mineral density, falls and neuromuscular performance. Particular the investigators compare a bipedal vertical oscillating Plate with a plate which rotates around a central axis leading to a side-alternating loaning.

Condition or Disease Intervention/Treatment Phase
  • Device: vertical vibration device (Vibrafit whole body vibration platform)
  • Device: side alternating vibration device (Board 3000 whole body vibration platform)
  • Behavioral: stretching and wellness (control group)
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
108 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of Whole Body Vibration Training on Two Different Devices on Osteoporotic Risk Factors in Postmenopausal Women. A Randomized Controlled Trial.
Study Start Date :
Apr 1, 2008
Actual Primary Completion Date :
Jun 1, 2009
Actual Study Completion Date :
Nov 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

vertical vibration device (using Vibrafit whole body vibration platforms)

Device: vertical vibration device (Vibrafit whole body vibration platform)
3 sessions/week 15 min each, leg exercises performed on whole body vibration platforms with vertical device

Active Comparator: 2

side-alternating vibration device (using Board 3000 whole body vibration platforms)

Device: side alternating vibration device (Board 3000 whole body vibration platform)
3 sessions/week 15 min each, leg exercises performed on whole body vibration platforms with side alternating device

Sham Comparator: 3

wellness-control group

Behavioral: stretching and wellness (control group)
2x10 weeks with 1 session/week of low volume, low intensity wellness training over 12 months

Outcome Measures

Primary Outcome Measures

  1. Bone Mineral Density [Baseline, 12 months]

Secondary Outcome Measures

  1. muscle strength [baseline, 12 months]

  2. Quality of life [baseline, 12 month]

  3. falls [daily over 12 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • females 60 - 75 years old

  • caucasian race

Exclusion Criteria:
  • CHD-diseases

  • thrombosis, embolism

  • fractures at lumbar spine or hip

  • secondary osteoporosis

  • hyperparathyroidism

  • medication, diseases with impact on muscle or bone

  • hip or knee implant

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute of Medical Physics, University of Erlangen-Nurnberg Erlangen Germany 91052

Sponsors and Collaborators

  • University of Erlangen-Nürnberg Medical School
  • Elsbeth-Bonhoff-Stiftung, Berlin

Investigators

  • Principal Investigator: Simon O von Stengel, PhD, University of Erlangen-Nürnberg Medical School
  • Study Chair: Wolfgang K Kemmler, PhD, Instiute of Medical Physics
  • Study Director: Willi A Kalender, Prof., PhD, University of Erlangen-Nürnberg Medical School

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Wolfgang Kemmler, Principal Investigator, University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier:
NCT00667667
Other Study ID Numbers:
  • OFZ-Elvis-II
First Posted:
Apr 28, 2008
Last Update Posted:
May 28, 2015
Last Verified:
May 1, 2015
Keywords provided by Wolfgang Kemmler, Principal Investigator, University of Erlangen-Nürnberg Medical School

Study Results

No Results Posted as of May 28, 2015